Overview and Scope
Therapeutic plasma exchange (TPE) refers to a medical procedure used to treat certain autoimmune diseases and other conditions. During TPE, blood is removed from the body, plasma (the liquid portion of the blood) is separated from the blood cells, and then the blood cells are returned to the body, often after being mixed with a replacement fluid. This process helps remove harmful substances from the blood, such as autoantibodies or toxins, which can contribute to various diseases.
Sizing and Forecast
The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.35 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.
The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Segmentation & Regional Insights
The therapeutic plasma exchange market covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users
North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
Major Driver Impacting Market Growth
The high prevalence of hematological disorders is expected to propel the growth of the therapeutic plasma exchange market going forward. Hematological disorders, also known as blood disorders, refer to medical conditions that affect the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. Hematological disorders are rising due to factors including genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) is utilized in hematological disorders to remove pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby mitigating disease severity and improving patient outcomes. For instance, in August 2023, according to the Leukemia and Lymphoma Society, a US-based professional organization, the number of projected myeloma diagnoses is expected to rise by around 2.3% from 2021 to 2023, increasing from 34,920 to 35,730, respectively. Therefore, the high prevalence of hematological disorders is driving the growth of the therapeutic plasma exchange market.
Key Industry Players
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.
The therapeutic plasma exchange market report table of contents includes:
1. Executive Summary
2. Therapeutic Plasma Exchange Market Characteristics
3. Therapeutic Plasma Exchange Market Trends And Strategies
4. Therapeutic Plasma Exchange Market – Macro Economic Scenario
5. Global Therapeutic Plasma Exchange Market Size and Growth
.
.
.
32. Global Therapeutic Plasma Exchange Market Competitive Benchmarking
33. Global Therapeutic Plasma Exchange Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Therapeutic Plasma Exchange Market
35. Therapeutic Plasma Exchange Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
